Joshua A. Hill

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

Robert Gottlieb, Carlos Vaca, Roger Paredes et al. · New England Journal of Medicine · 2021 · 1.3K citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

Multiple early factors anticipate post-acute COVID-19 sequelae

Yapeng Su, Dan Yuan, Daniel Chen et al. · Cell · 2022 · 1.2K citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Infectious complications of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy

Joshua A. Hill, Daniel Li, Kevin A. Hay et al. · Blood · 2017 · 566 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells

Ana Cordeiro, Evandro D. Bezerra, Alexandre V. Hirayama et al. · Biology of Blood and Marrow Transplantation · 2019 · 351 citations · Full text

Life Sciences, Hematology, Immunology +9

Extrathymic T Cell Deletion and Allogeneic Stem Cell Engraftment Induced with Costimulatory Blockade Is Followed by Central T Cell Tolerance

Thomas Wekerle, Mohamed H. Sayegh, Joshua A. Hill et al. · The Journal of Experimental Medicine · 1998 · 340 citations · Full text

Life Sciences, Cell Biology, Immunology +17